Back to News
quantum-computing

Cardinal Health (CAH) Is Up 2.00% in One Week: What You Should Know

Zacks
Loading...
6 min read
0 likes
⚡ Quantum Brief
Cardinal Health surged 2% in one week, outperforming its industry’s 0.57% gain, signaling strong short-term momentum in the medical-dental supplies sector. The stock holds a Zacks Momentum Style Score of A and a #2 (Buy) rank, with research showing such stocks often outperform the market over the next month. Longer-term trends are bullish: CAH rose 29.59% over one month and 73.81% year-over-year, crushing the S&P 500’s 14.42% annual gain. Earnings estimates revised upward—full-year consensus jumped from $9.45 to $9.86 in 60 days—with no downward revisions, reinforcing positive sentiment. Trading volume averages 2.9 million shares daily, with above-average volume during rallies, suggesting sustained investor interest and potential for continued upside.
AI Audio Summary
0:00 / 0:00
Click to play
Quantum computing technology
Unsplash · Validated Fallback

AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA Stocks Cardinal Health (CAH) Is Up 2.00% in One Week: What You Should Know November 27, 2025 — 12:00 pm EST Written by Zacks Equity Research for Zacks-> Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving that way. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.While many investors like to look for momentum in stocks, this can be very tough to define. There is a lot of debate surrounding which metrics are the best to focus on and which are poor quality indicators of future performance.

The Zacks Momentum Style Score, part of the Zacks Style Scores, helps address this issue for us. Below, we take a look at Cardinal Health (CAH), which currently has a Momentum Style Score of A. We also discuss some of the main drivers of the Momentum Style Score, like price change and earnings estimate revisions.It's also important to note that Style Scores work as a complement to the Zacks Rank, our stock rating system that has an impressive track record of outperformance. Cardinal Health currently has a Zacks Rank of #2 (Buy). Our research shows that stocks rated Zacks Rank #1 (Strong Buy) and #2 (Buy) and Style Scores of "A or B" outperform the market over the following one-month period.You can see the current list of Zacks #1 Rank Stocks here >>> Set to Beat the Market? In order to see if CAH is a promising momentum pick, let's examine some Momentum Style elements to see if this prescription drug distributor holds up.Looking at a stock's short-term price activity is a great way to gauge if it has momentum, since this can reflect both the current interest in a stock and if buyers or sellers have the upper hand at the moment. It's also helpful to compare a security to its industry; this can show investors the best companies in a particular area. For CAH, shares are up 2% over the past week while the Zacks Medical - Dental Supplies industry is up 0.57% over the same time period. Shares are looking quite well from a longer time frame too, as the monthly price change of 29.59% compares favorably with the industry's 3.41% performance as well.While any stock can see a spike in price, it takes a real winner to consistently outperform the market. Over the past quarter, shares of Cardinal Health have risen 41.56%, and are up 73.81% in the last year. In comparison, the S&P 500 has only moved 5.68% and 14.42%, respectively.Investors should also pay attention to CAH's average 20-day trading volume. Volume is a useful item in many ways, and the 20-day average establishes a good price-to-volume baseline; a rising stock with above average volume is generally a bullish sign, whereas a declining stock on above average volume is typically bearish. CAH is currently averaging 2,914,504 shares for the last 20 days.Earnings OutlookThe Zacks Momentum Style Score also takes into account trends in estimate revisions, in addition to price changes. Please note that estimate revision trends remain at the core of Zacks Rank as well. A nice path here can help show promise, and we have recently been seeing that with CAH.Over the past two months, 7 earnings estimates moved higher compared to none lower for the full year. These revisions helped boost CAH's consensus estimate, increasing from $9.45 to $9.86 in the past 60 days. Looking at the next fiscal year, 6 estimates have moved upwards while there have been no downward revisions in the same time period. Bottom LineTaking into account all of these elements, it should come as no surprise that CAH is a #2 (Buy) stock with a Momentum Score of A. If you've been searching for a fresh pick that's set to rise in the near-term, make sure to keep Cardinal Health on your short list.

Quantum Computing Stocks Set To Soar Artificial intelligence has already reshaped the investment landscape, and its convergence with quantum computing could lead to the most significant wealth-building opportunities of our time. Today, you have a chance to position your portfolio at the forefront of this technological revolution. In our urgent special report, Beyond AI: The Quantum Leap in Computing Power, you'll discover the little-known stocks we believe will win the quantum computing race and deliver massive gains to early investors.Access the Report Free Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free reportCardinal Health, Inc. (CAH) : Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment Research The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Tags StocksInvestingHow to Invest Zacks Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com. More articles by this source-> Stocks mentioned CAH More Related Articles This data feed is not available at this time. Data is currently not available • Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.

Read Original

Source Information

Discussion

0 professional contributions

Sign in to join this professional discussion.

Be the first to add a constructive contribution.